Huet D et al. |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment]. |
2017 |
Rev Mal Respir |
pmid:27639948
|
Camara B et al. |
[Infection due to Mycobacterium malmoense in an immunocompetent patient]. |
2008 |
Rev Mal Respir |
pmid:19106910
|
Schubel K et al. |
[Pleuropneumonia due to Mycobacterium chelonae]. |
2011 |
Rev Mal Respir |
pmid:21482339
|
Dixmier A et al. |
[Pulmonary infections with Mycobacterium xenopi in patients without HIV infection]. |
2007 |
Rev Mal Respir |
pmid:17417167
|
Frija-Masson J et al. |
[Non-tuberculous mycobacterial infection of a totally implanted perfusion device]. |
2015 |
Rev Mal Respir |
pmid:25480387
|
Gomez-Abreo D et al. |
[Chronic necrotizing pulmonary aspergillosis following an infection by Mycobacterium malmoense]. |
2012 |
Rev Mal Respir |
pmid:22440310
|
González C et al. |
[In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin]. |
2001 |
Rev Med Chil |
pmid:11510204
|
Pavié G J et al. |
[Assessment of the management of community-acquired pneumonia in adults outpatients]. |
2005 |
Rev Med Chil |
pmid:16446856
|
Sánchez H et al. |
[Compliance with guidelines for the management of community acquired pneumonia at primary health care centers]. |
2009 |
Rev Med Chil |
pmid:20361133
|
Alvarez A et al. |
[Antimicrobial susceptibility of Helicobacter pylori strains isolated in Colombia]. |
2009 |
Rev Med Chil |
pmid:20011937
|
Fariña N et al. |
[Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients]. |
2007 |
Rev Med Chil |
pmid:17989858
|
GarcÃa-Agudo L et al. |
[Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test]. |
2009 |
Rev Med Chil |
pmid:19802419
|
Vallejos C et al. |
[Prevalence of metronidazole, clarithromycin and tetracycline resistance in Helicobacter pylori isolated from Chilean patients]. |
2007 |
Rev Med Chil |
pmid:17505573
|
Poiată A et al. |
[Meropenem activity against staphylococci]. |
2005 Jan-Mar |
Rev Med Chir Soc Med Nat Iasi |
pmid:16607852
|
Niang M et al. |
[Painful nodular lesions]. |
1998 |
Rev Med Interne |
pmid:9793156
|
Cinquetti G et al. |
[Rare complications of Lemierre's syndrome: septic sternoclavicular joint arthritis and cavitating pneumonia]. |
2009 |
Rev Med Interne |
pmid:19896753
|
Leclercq V et al. |
[Avoidable adverse event: carbamazepine encephalopathy when introducing clarithromycine]. |
2005 |
Rev Med Interne |
pmid:16023268
|
de Korwin JD |
[Helicobacter pylori infection and antimicrobial agents resistance]. |
2004 |
Rev Med Interne |
pmid:14736561
|
Scheen AJ |
[Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. |
1998 |
Rev Med Liege |
pmid:9555183
|
Lutgen N et al. |
[Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege]. |
2001 |
Rev Med Liege |
pmid:11256133
|
Guiot J et al. |
[Mycobacterium malmoense infection in an immunocompetent patient]. |
2009 Jul-Aug |
Rev Med Liege |
pmid:19777918
|
Flores-Gonzalez JC et al. |
[Etiology, clinical presentation and outcome of severe viral acute childhood encephalitis (ECOVE study)]. |
2015 |
Rev Neurol |
pmid:26108903
|
Dautzenberg B |
[Treatment of atypical mycobacterium infections: current state and therapeutic perspectives]. |
1992 |
Rev Pneumol Clin |
pmid:1296257
|
Melo-Cristino J et al. |
The Viriato Study: update of antimicrobial susceptibility data of bacterial pathogens from community-acquired respiratory tract infections in Portugal in 2003 and 2004. |
|
Rev Port Pneumol |
pmid:16572254
|
Bronstein JA |
[National ranking exam. N63. What could fall at the exam?]. |
2008 |
Rev Prat |
pmid:18506983
|
Lamouliatte H et al. |
[Treatment of Helicobacter pylori infection]. |
2000 |
Rev Prat |
pmid:11019637
|
Roche B et al. |
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi. |
1997 |
Rev Rhum Engl Ed |
pmid:9051864
|
Colomina RodrÃguez J et al. |
[Impact of Integrated Model for Rational Use of Antibiotics in a health area (project MIURA)]. |
|
Rev. Esp. Salud Publica |
pmid:20661527
|
Ramzy I et al. |
GENETIC MUTATIONS AFFECTING THE FIRST LINE ERADICATION THERAPY OF Helicobacter pylori-INFECTED EGYPTIAN PATIENTS. |
2016 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:27982354
|
Picoli SU et al. |
Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients. |
2014 May-Jun |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:24878996
|
Vianna JS et al. |
The interplay between mutations in cagA, 23S rRNA, gyrA and drug resistance in Helicobacter pylori. |
2018 |
Rev. Inst. Med. Trop. Sao Paulo |
pmid:29972462
|
Estrada-Gómez RA et al. |
Helicobacter pylori infection and thrombocytopenia: a single-institution experience in Mexico. |
2007 Mar-Apr |
Rev. Invest. Clin. |
pmid:17633798
|
Leal YA et al. |
A primary Helicobacter pylori infection does not protect against reinfection in children after eradication therapy. |
2008 Nov-Dec |
Rev. Invest. Clin. |
pmid:19378833
|
Gutiérrez-Castrellón P et al. |
Efficacy and safety of clarithromycin in pediatric patients with upper respiratory infections: a systematic review with meta-analysis. |
2012 Mar-Apr |
Rev. Invest. Clin. |
pmid:22991774
|
Gélisse P et al. |
[Carbamazepine and clarithromycin: a clinically relevant drug interaction]. |
2007 |
Rev. Neurol. (Paris) |
pmid:18033049
|
Dalston MO et al. |
[Clarithromycin combined with pyrimethamine in cerebral toxoplasmosis--a report of 2 cases]. |
1995 Oct-Dec |
Rev. Soc. Bras. Med. Trop. |
pmid:8668843
|
Caliskan R et al. |
Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. |
|
Rev. Soc. Bras. Med. Trop. |
pmid:26108005
|
Paina FA et al. |
[Hematological, hemostatic and biochemical alterations induced by clofazimine and clarithromycin, in single and multiple doses, in rats]. |
2008 May-Jun |
Rev. Soc. Bras. Med. Trop. |
pmid:18719809
|
Andereya S et al. |
Reactive knee and ankle joint arthritis: abnormal manifestation of Legionella pneumophila. |
2004 |
Rheumatol. Int. |
pmid:14513269
|
Cohen O et al. |
Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori. |
2015 |
Rheumatol. Int. |
pmid:26210999
|
Saviola G et al. |
Clarithromycin in rheumatoid arthritis: the addition to methotrexate and low-dose methylprednisolone induces a significant additive value--a 24-month single-blind pilot study. |
2013 |
Rheumatol. Int. |
pmid:23864141
|
Breda L et al. |
Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children. |
2009 |
Rheumatol. Int. |
pmid:19156420
|
Saviola G et al. |
Clarithromycin in adult-onset Still's disease: a study of 6 cases. |
2010 |
Rheumatol. Int. |
pmid:20033412
|
O'Connor MB et al. |
Rituximab-induced pulmonary disease. |
2012 |
Rheumatol. Int. |
pmid:21892654
|
Haj Yahia S et al. |
Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients. |
2018 |
Rheumatol. Int. |
pmid:28975396
|
Furuya H et al. |
SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. |
2017 |
Rheumatology (Oxford) |
pmid:28371927
|
Cervin A and Wallwork B |
Macrolide therapy of chronic rhinosinusitis. |
2007 |
Rhinology |
pmid:18085018
|
Stefansson P et al. |
Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. |
1998 |
Rhinology |
pmid:9923060
|
Haruna S et al. |
A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis. |
2009 |
Rhinology |
pmid:19382498
|
Murata Y et al. |
[Study on the detection methods of Helicobacter pylori from clinical specimens]. |
2002 |
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi |
pmid:11895427
|
Yamane N et al. |
[Multicenter evaluation of a newly developed microdilution test, brothMIC NTM to determine minimum inhibitory concentrations of antimicrobial agents for nontuberculous mycobacteria]. |
2002 |
Rinsho Byori |
pmid:12014018
|
Ozawa S |
[Drug-drug interaction in pharmacogenetics and pharmacogenomics]. |
2002 |
Rinsho Byori |
pmid:11925851
|
Tomita A et al. |
[Analysis of the macrolide resistance gene in penicillin-resistant Streptococcus pneumoniae]. |
2006 |
Rinsho Byori |
pmid:16989397
|
Egashira T |
[Development and clinical application of invader assay--detection of resistant mutation to clarithromycin in Helicobacter pylori]. |
2006 |
Rinsho Byori |
pmid:16548239
|
Kodama M and Fujioka T |
[Eradication therapy of Helicobacter pylori infection]. |
2001 |
Rinsho Byori |
pmid:11307304
|
Fukuda Y et al. |
[The history of Helicobacter pylori]. |
2001 |
Rinsho Byori |
pmid:11307300
|
Chen G et al. |
[The cause of failure of eradication treatment of Helicobacter pylori]. |
2005 |
Rinsho Byori |
pmid:16190353
|
Ohe M and Kohno M |
[Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment]. |
2003 |
Rinsho Ketsueki |
pmid:14639954
|
Goto H et al. |
[Successful treatment of refractory idiopathic thrombocytopenic purpura by eradication of Helicobacter pylori]. |
2001 |
Rinsho Ketsueki |
pmid:11828723
|
Sakabe H et al. |
[Successful treatment of long-standing iron-deficiency anemia in adults by eradication of Helicobacter pylori]. |
2004 |
Rinsho Ketsueki |
pmid:15199751
|
MORITA R et al. |
Iron deficiency anemia successfully treated by Helicobacter pylori eradication in a patient with idiopathic thrombocytopenic purpura. |
2009 |
Rinsho Ketsueki |
pmid:20009444
|
Yanagimachi M et al. |
[Cutaneous non-tuberculous mycobacterial infection following cord blood stem cell transplantation]. |
2008 |
Rinsho Ketsueki |
pmid:18341040
|
Takahashi T et al. |
[Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura]. |
2006 |
Rinsho Ketsueki |
pmid:16784096
|
Ohe M and Hashino S |
[Successful treatment with clarithromycin for Mixed phenotype acute leukemia, T/myeloid, NOS]. |
2010 |
Rinsho Ketsueki |
pmid:20467229
|
Fujikawa K et al. |
[A case of Mycobacterium fortuitum meningitis following surgery for meningioma]. |
2006 |
Rinsho Shinkeigaku |
pmid:17061701
|
|
AIDS patients have a new weapon against MAC infection. |
1994 |
RN |
pmid:8128150
|
Sakatani M |
[Multi-drug resistant mycobacterial infection]. |
1999 |
Ryoikibetsu Shokogun Shirizu |
pmid:10088372
|
Kimang'a AN et al. |
Helicobacter pylori: prevalence and antibiotic susceptibility among Kenyans. |
2010 |
S. Afr. Med. J. |
pmid:20429490
|
Laving A et al. |
Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya. |
2013 |
S. Afr. Med. J. |
pmid:24300630
|
Bellelis P et al. |
Efficacy of a triple therapy for Helicobacter pylori eradication in a well-developed urban area in Brazil. |
2004 |
Sao Paulo Med J |
pmid:15257365
|
Eisig JN et al. |
Therapeutic efficacy of ranitidine bismuth citrate with clarithromycin for seven days in the eradication of Helicobacter pylori in Brazilian peptic ulcer patients. |
2003 |
Sao Paulo Med J |
pmid:12751338
|
Baba K et al. |
A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. |
2006 |
Sarcoidosis Vasc Diffuse Lung Dis |
pmid:16933475
|
Alsohaibani F et al. |
Prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection. |
|
Saudi J Gastroenterol |
pmid:26228365
|
Zullo A et al. |
Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis. |
|
Saudi J Gastroenterol |
pmid:22249086
|
Agah S et al. |
Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia. |
2009 Oct-Dec |
Saudi J Gastroenterol |
pmid:19794266
|
Kekilli M et al. |
Inefficacy of triple therapy and comparison of two different bismuth-containing quadruple regimens as a firstline treatment option for helicobacter pylori. |
|
Saudi J Gastroenterol |
pmid:27748322
|
Rajendiran S et al. |
Increased protein carbonylation and decreased antioxidant status in anemic H. pylori infected patients: effect of treatment. |
2012 Jul-Aug |
Saudi J Gastroenterol |
pmid:22824768
|
Hu JL et al. |
Optimized high-dose amoxicillin-proton-pump inhibitor dual therapies fail to achieve high cure rates in China. |
|
Saudi J Gastroenterol |
pmid:28937021
|
Abadi AT et al. |
High frequency of A2143G mutation in clarithromycin-resistant Helicobacter pylori isolates recovered from dyspeptic patients in Iran. |
2011 Nov-Dec |
Saudi J Gastroenterol |
pmid:22064338
|
Dajani AI et al. |
Do probiotics improve eradication response to Helicobacter pylori on standard triple or sequential therapy? |
2013 May-Jun |
Saudi J Gastroenterol |
pmid:23680708
|
Zhang SH et al. |
The effect of virulence genotypes of on eradication therapy in children. |
|
Saudi J Gastroenterol |
pmid:29652033
|
Al Majid FM |
Peritonitis due to Mycobacterium fortuitum following gastric banding. |
|
Saudi J Gastroenterol |
pmid:20339182
|
Shokrzadeh L et al. |
Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran. |
|
Saudi J Gastroenterol |
pmid:21727733
|
Hasan SR et al. |
Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of Helicobacter pylori. |
|
Saudi J Gastroenterol |
pmid:20065568
|
Khan MQ |
Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial. |
2008 |
Saudi J Gastroenterol |
pmid:19568511
|
Wang J et al. |
Two-week triple therapy has a higher Helicobacter pylori eradication rate than 1-week therapy: A single-center randomized study. |
|
Saudi J Gastroenterol |
pmid:26655129
|
Pellicano R and Fagoonee S |
One or two weeks of treatment with Helicobacter Pylori ''standard'' triple therapy in the year 2015? |
|
Saudi J Gastroenterol |
pmid:26655127
|
Dajani A et al. |
Importance of Helicobacter pylori eradcation for maintenance of remission of drug associated peptic ulcer disease. |
|
Saudi J Gastroenterol |
pmid:19858579
|
Salem EM et al. |
Comparative study of Nigella Sativa and triple therapy in eradication of Helicobacter Pylori in patients with non-ulcer dyspepsia. |
2010 Jul-Sep |
Saudi J Gastroenterol |
pmid:20616418
|
Bezmin Abadi AT et al. |
Inefficiency of rapid urease test for confirmation of Helicobacter pylori. |
|
Saudi J Gastroenterol |
pmid:21196663
|
Rajindrajith S et al. |
Helicobacter pylori infection in children. |
2009 |
Saudi J Gastroenterol |
pmid:19568571
|
Ranganathan D et al. |
Mycobacterium fortuitum peritonitis in a patient receiving continuous ambulatory peritoneal dialysis. |
2013 |
Saudi J Kidney Dis Transpl |
pmid:24029271
|
Vafaeimanesh J et al. |
Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients. |
2014 |
Saudi J Kidney Dis Transpl |
pmid:24434382
|
Alfaresi MS et al. |
Molecular prevalence of point mutations conferring resistance to clarithromycin in Helicobacter pylori in the United Arab Emirates. |
2005 |
Saudi Med J |
pmid:15951866
|
Ghazzawi IM et al. |
Triple therapy with pantoprazole, clarithromycin and amoxicillin for eradication in patients with Helicobacter pylori positive duodenal ulcers. |
2004 |
Saudi Med J |
pmid:15322588
|
Al-Mobeireek AF |
Rapidly growing mycobacterial pulmonary infection in association with severe gastroesophageal reflux disease. |
2002 |
Saudi Med J |
pmid:12174240
|
Celen MK et al. |
Development of pneumatoceles after viral infection. |
2006 |
Saudi Med J |
pmid:16830037
|
Bindayna KM |
Antibiotic susceptibilities of Helicobacter pylori. |
2001 |
Saudi Med J |
pmid:11255612
|
Paakkanen R et al. |
Beneficial effect of clarithromycin in patients with acute coronary syndrome and complement C4 deficiencies. |
2009 |
Scand. Cardiovasc. J. |
pmid:19365786
|
Bjerre M et al. |
Osteoprotegerin independently predicts mortality in patients with stable coronary artery disease: the CLARICOR trial. |
2014 |
Scand. J. Clin. Lab. Invest. |
pmid:25026506
|